metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis
ISSN: 0214-9168

See more Open Access Option
Clínica e Investigación en Arteriosclerosis ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

"Notas metodológicas": una nueva e importante sección en Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

See more

Follow us:

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2023
1.9
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2023
3.2
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2023
0.424
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2023
0.435
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study
Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Antonio Segura Fragoso, Verónica Fernández-Pascual, Beatriz Sánchez-Sánchez, María Inmaculada Cervera-Pérez, Francisco Javier Alonso-Moreno, ... on behalf of the Investigators of the AGORA study, of the Spanish Society of Primary Care Physicians SEMERGEN Foundation
Available online 24 June 2024
Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular risk markers
Oscar Zaragoza-García, Olivia Briceño, José Rafael Villafan-Bernal, Ilse Adriana Gutiérrez-Pérez, Héctor Ugo Rojas-Delgado, Gustavo Adolfo Alonso-Silverio, Antonio Alarcón-Paredes, José Eduardo Navarro-Zarza, ... Iris Paola Guzmán-Guzmán
Available online 10 May 2024
Modelo de cocultivo 3D in vitro de células endoteliales y vasculares de músculo liso humanas para el estudio del remodelado vascular patológico
Irene San Sebastián-Jaraba, María José Fernández-Gómez, Rafael Blázquez-Serra, Sandra Sanz-Andrea, Luis Miguel Blanco-Colio, Nerea Méndez-Barbero
Full text access
Open Article
Available online 9 May 2024
View all Ahead of print
Current Issue
Issue
Vol. 36. Issue 3.
Pages 101-200 (May - June 2024)
Originals
Validation of the IberScore model in a primary care population
Carlos Fernández-Labandera Ramos, Irene Moral, Carlos Brotons, Luis Quevedo Aguado, Inmaculada Coca Prieto, Pedro Valdivielso, Miguel Ángel Sánchez Chaparro
Clin Invest Arterioscl. 2024;36:101-7
Impacto del tratamiento con rolipram sobre la homeostasis rédox y la señalización celular en un modelo experimental de aneurisma de aorta abdominal
Lídia Puertas-Umbert, Judith Alonso, Elena Roselló-Díez, Alicia Santamaría-Orleans, José Martínez-González, Cristina Rodríguez
Clin Invest Arterioscl. 2024;36:108-17
Análisis clínico-epidemiológico de pacientes con lipoproteína(a) elevada en un hospital de tercer nivel
Manuel García de Prada, Ramón Costa Segovia, Marta de Castro Martínez, Nuria Valdeolivas Hidalgo, María Belén Sánchez López, Agustín Blanco Echevarría
Clin Invest Arterioscl. 2024;36:118-25
Editorial
View all issue
Free access article
ARTÍCULO ESPECIAL
Prevención cardiovascular en la diabetes mellitus. ¿Es adecuado hablar de riesgo moderado o intermedio?
Sergio Martínez-Hervás, José T. Real, Rafael Carmena, Juan F. Ascaso
10.1016/j.arteri.2023.10.003
Clin Invest Arterioscl. 2024;36:80-5
Highlighted articles
“Notas metodológicas”: una nueva e importante sección en Clínica e Investigación en Arteriosclerosis
Josep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Invest Arterioscl. 2023;35:243
Open Article
Consenso sobre lipoproteína (a) de la Sociedad Española de Arteriosclerosis. Revisión bibliográfica y recomendaciones para la práctica clínica
Javier Delgado-Lista, Jose M. Mostaza, Teresa Arrobas-Velilla, Francisco Blanco-Vaca, Luis Masana, Juan Pedro-Botet, Pablo Perez-Martinez, Fernando Civeira, ... Carlos Guijarro
Open Article
Available online 10 April 2024
View all highlighted articles
Archive
View all archive
Supplements
View all supplements
Instructions for authors
Most often read
ARTÍCULO ESPECIAL
José María Mostaza, Xavier Pintó, Pedro Armario, Luis Masana, José T. Real, Pedro Valdivielso, Teresa Arrobas-Velilla, Ramón Baeza-Trinidad, Pilar Calmarza, Jesús Cebollada, Miguel Civera-Andrés, José I. Cuende Melero, José L. Díaz-Díaz, Javier Espíldora-Hernández, Jacinto Fernández Pardo, Carlos Guijarro, Carles Jericó, Martín Laclaustra, Carlos Lahoz, José López-Miranda, Sergio Martínez-Hervás, Ovidio Muñiz-Grijalvo, José A. Páramo, Vicente Pascual, Juan Pedro-Botet, Pablo Pérez-Martínez, José Puzo
10.1016/j.arteri.2024.02.001
Clin Invest Arterioscl. 2024;36:133-94
This article has been read 5.649 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos